Trabectedin – the DNA minor groove binder

Trabectedin (ET-743, Yondelis) is an alkaloid that was originally isolated from the Caribbean Sea squirt, Ecteinascidia turbinata and is now produced synthetically. Its chemical structure consists in three fused tetrahydroisoquinoline rings. Two of them, A and B, binds covalently to guanine residues...

Full description

Saved in:
Bibliographic Details
Main Authors: G. A. Belitsky, K. I. Kirsanov, E. A. Lesovaya, M. G. Yakubovskaya
Format: Article
Language:Russian
Published: ABV-press 2015-06-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850024950437511168
author G. A. Belitsky
K. I. Kirsanov
E. A. Lesovaya
M. G. Yakubovskaya
author_facet G. A. Belitsky
K. I. Kirsanov
E. A. Lesovaya
M. G. Yakubovskaya
author_sort G. A. Belitsky
collection DOAJ
description Trabectedin (ET-743, Yondelis) is an alkaloid that was originally isolated from the Caribbean Sea squirt, Ecteinascidia turbinata and is now produced synthetically. Its chemical structure consists in three fused tetrahydroisoquinoline rings. Two of them, A and B, binds covalently to guanine residues in the minor groove of the DNA double helix to bend the molecule toward the major groove and the third ring C protrudes from the DNA duplex, apparently allowing interactions with several nuclear proteins. Binding to the minor groove of DNA, trabectedin trigger a cascade of events that interfere with several transcription factors, DNA binding proteins, and DNA repair pathways in particular nucleotide excision repair. It acts both as a DNA-alkylating drug and topoisomerase poison. Trabectedin-DNA adduct traps the nucleotide excision repair proteins repairing the DNA damage in transcribing genes and induces DNA strand breaks. Cells deficient in homologous recombination pathway which repairs these double-strand breaks show increased sensitivity to trabectedin. The most sensitive of them were myxoid liposarcomas. Trabectedin is also effective in chemotherapy-experienced patients with advanced, recurrent liposarcoma or leiomyosarcoma as well as in women with ovarian cancer and breast cancer with BRCAness phenotype. Besides of tumor cells Trabectedin inhibits inflammatory cells by affecting directly monocytes and tumorassociated macrophages and indirectly by inhibiting production of inflammatory mediators, the cytokines and chemokines. It inhibits also the MDR-1 gene, which is responsible for the resistance of cancer cells to chemotherapeutic agents and strikes tumor angiogenesis.
format Article
id doaj-art-47fdfb76db1a4c87b59ebae675e3b29c
institution DOAJ
issn 2313-805X
2413-3787
language Russian
publishDate 2015-06-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj-art-47fdfb76db1a4c87b59ebae675e3b29c2025-08-20T03:00:58ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872015-06-0122414910.17650/2313-805X.2015.2.2.41-4924Trabectedin – the DNA minor groove binderG. A. Belitsky0K. I. Kirsanov1E. A. Lesovaya2M. G. Yakubovskaya3N.N. Blokhin Russian Cancer Research CenterN.N. Blokhin Russian Cancer Research CenterN.N. Blokhin Russian Cancer Research CenterN.N. Blokhin Russian Cancer Research CenterTrabectedin (ET-743, Yondelis) is an alkaloid that was originally isolated from the Caribbean Sea squirt, Ecteinascidia turbinata and is now produced synthetically. Its chemical structure consists in three fused tetrahydroisoquinoline rings. Two of them, A and B, binds covalently to guanine residues in the minor groove of the DNA double helix to bend the molecule toward the major groove and the third ring C protrudes from the DNA duplex, apparently allowing interactions with several nuclear proteins. Binding to the minor groove of DNA, trabectedin trigger a cascade of events that interfere with several transcription factors, DNA binding proteins, and DNA repair pathways in particular nucleotide excision repair. It acts both as a DNA-alkylating drug and topoisomerase poison. Trabectedin-DNA adduct traps the nucleotide excision repair proteins repairing the DNA damage in transcribing genes and induces DNA strand breaks. Cells deficient in homologous recombination pathway which repairs these double-strand breaks show increased sensitivity to trabectedin. The most sensitive of them were myxoid liposarcomas. Trabectedin is also effective in chemotherapy-experienced patients with advanced, recurrent liposarcoma or leiomyosarcoma as well as in women with ovarian cancer and breast cancer with BRCAness phenotype. Besides of tumor cells Trabectedin inhibits inflammatory cells by affecting directly monocytes and tumorassociated macrophages and indirectly by inhibiting production of inflammatory mediators, the cytokines and chemokines. It inhibits also the MDR-1 gene, which is responsible for the resistance of cancer cells to chemotherapeutic agents and strikes tumor angiogenesis.https://umo.abvpress.ru/jour/article/view/24trabectedindna minor grooveligandmalignant tumorchemotherapydna repairrecombinationmetabolismhepatotoxicity
spellingShingle G. A. Belitsky
K. I. Kirsanov
E. A. Lesovaya
M. G. Yakubovskaya
Trabectedin – the DNA minor groove binder
Успехи молекулярной онкологии
trabectedin
dna minor groove
ligand
malignant tumor
chemotherapy
dna repair
recombination
metabolism
hepatotoxicity
title Trabectedin – the DNA minor groove binder
title_full Trabectedin – the DNA minor groove binder
title_fullStr Trabectedin – the DNA minor groove binder
title_full_unstemmed Trabectedin – the DNA minor groove binder
title_short Trabectedin – the DNA minor groove binder
title_sort trabectedin the dna minor groove binder
topic trabectedin
dna minor groove
ligand
malignant tumor
chemotherapy
dna repair
recombination
metabolism
hepatotoxicity
url https://umo.abvpress.ru/jour/article/view/24
work_keys_str_mv AT gabelitsky trabectedinthednaminorgroovebinder
AT kikirsanov trabectedinthednaminorgroovebinder
AT ealesovaya trabectedinthednaminorgroovebinder
AT mgyakubovskaya trabectedinthednaminorgroovebinder